The US National Institutes of Health has announced the launch of a Phase 1/2 clinical trial. Adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
This vaccine study will include approximately 150 individuals who already have received one of the three COVID-19 vaccine regimens currently available under FDA Emergency Use Authorization in the USA.
Mixed COVID-19 Vaccine Study Launches
Detection of SARS-CoV-2 virus using an alternative molecular method and evaluation of biochemical, hematological, inflammatory, and oxidative stress in healthcare professionals.
In early December 2019, an outbreak of coronavirus disease 2019 caused by a new strain of coronavirus (SARS-CoV-2), occurred in the city of Wuhan, Hubei Province, China. On January 30, […]
A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.
Latin America accounts for one-quarter of global COVID-19 cases and one-third of deaths. Inequalities in the region lead to barriers regarding the best use of diagnostic tests during the pandemic. […]
Childhood immunization during the COVID-19 pandemic in Texas.
In 2020, the state of Texas implemented coronavirus disease 2019 (COVID-19) social distancing guidelines in order to prevent surges at Texas hospital emergency rooms and in intensive care units. As […]
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy.
We report the first registered cases of cutaneous adverse reactions in North-East Italy after the m-RNA COVID-19 vaccine Comirnaty®-BioNTech/Pfizer, During January 2021, in the public health jurisdiction of Trieste, a […]
Detection of SARS-CoV-2 genome and whole transcriptome sequencing in Frontal Cortex of COVID-19 patients.
SARS-Cov-2 infection is frequently associated with Nervous System manifestations. However, it is not clear how SARS-CoV-2 can cause neurological dysfunctions and which molecular processes are affected in the brain. In […]
Influenza Virus and SARS-CoV-2 Vaccines.
Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome […]
Nursing home deaths after COVID-19 vaccination.
In the period 27 December 2020 to 15 February 2021, about 29 400 of Norway’s roughly 35 000 nursing home patients were vaccinated with the mRNA vaccine BNT162b2. During the same period, […]
Preparedness for viral respiratory infection pandemic in residential aged care facilities: A review of the literature to inform post-COVID-19 response.
To examine what was known about disaster preparedness in residential care and to consider this in the light of the current COVID-19 pandemic.Care homes provide long-term care to vulnerable, frail […]
The impact of vitamin D supplementation on body fat mass in elite male collegiate athletes.
Whether vitamin D supplementation has any effect on body fat percentage, especially among elite athletes, remains unclear. The aim of this study was to evaluate the effect of vitamin D […]
- Page 1 of 2
- 1
- 2